X-Ceptor Therapeutics Inc.

The field of nuclear receptor drug discovery boasts few industrial-strength programs. X-Ceptor Therapeutics Inc., a 1999 spin-out from Ligand Pharmaceuticals Inc., is one of the few dedicated players in this area of drug discovery.